Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2011-07-26 Regulatory Filings
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Cleansing notice 1 page 42.2KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 27 July 2011 regarding a cleansing notice under section 708A of the Corporations Act 2001 (Cth). It discusses the placement of 60,000,000 shares and compliance with disclosure requirements. The document is short (1862 characters) and serves as a regulatory notice about a share placement without detailed financial data or a full report. It is not a full financial report, earnings release, or management discussion. It is an announcement related to capital raising activities but does not provide detailed financing terms or capital structure changes beyond the notice. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2011-07-26 English
Reinstatement to Official Quotation 1 page 9.8KB
Regulatory Filings
2011-07-21 English
Completion of Successful Capital raising 2 pages 123.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 22 July 2011 regarding the completion of a capital raising by Genetic Technologies Limited. It details the private placement of new shares, the issue price, the use of proceeds, and comments from the CEO. There are no financial statements or detailed financial performance data included, only an update on financing activity. The document is over 6000 characters, so it is not a brief notice but a full announcement. The content clearly relates to a capital raising event and changes in the company's capital structure. Therefore, the document fits best under the category 'Capital/Financing Update' (CAP).
2011-07-21 English
Response to ASX Price Query 3 pages 388.0KB
Regulatory Filings Classification · 100% confidence The document is a letter from ASX Compliance Pty Limited to Genetic Technologies Limited regarding a price and volume query related to the company's securities. It requests information about any undisclosed material information that could explain recent trading activity and compliance with listing rules. The letter references specific ASX listing rules (3.1 and 3.1A) and discusses the possibility of a trading halt. The content is regulatory in nature, focusing on compliance and disclosure obligations rather than financial results, management changes, or other report types. It does not contain financial statements, earnings data, or detailed report content. The document is a regulatory inquiry and compliance communication, fitting best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2011-07-21 English
Market update 2 pages 121.3KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 20 July 2011 providing a market update about Genetic Technologies Limited. It discusses the company's trading suspension, a proposed capital raising, and the expected finalization date of the capital raising. The content focuses on capital management and financing activities, including trading halts and voluntary suspension related to the capital raising process. There are no financial statements, detailed financial results, or comprehensive report data present. The document is not a full financial report but an update on financing activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (5163 characters) supports it being a substantive announcement rather than a brief notice or report publication announcement.
2011-07-19 English
Suspension from Official Quotation 2 pages 29.6KB
Regulatory Filings
2011-07-12 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.